In January 2006, the Patent Office of Chennai rejected the patent application by Novartis for patent of the drug Gleevec (chemically known as imatinib mesylate).
India, which followed the approach of process patenting to pharmaceuticals switched over to product patenting by way of an amendment in 2005 in order to
Although the imagery of the article from which this post takes it’s title, is hilarious; turn our movie theatres into war zones, with metal detectors,
I agree that the “predator” patent trolls can be potential lethal to companies who make and sell products, but I do not agree that their
Under traditional legal norms, US patent laws did not extend beyond the territorial bounds of the union. With a quick one-two punch, however, the US
Advertising plays an ever-increasing part in promoting competition and education for consumers. In such an era, web advertising has gained unprecedented popularity. By web-ad we
